Search

Search Constraints

You searched for: Author/Creator Cequier, Angel

Search Results

1. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. Issue 9962 (3rd January 2015)

2. ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison. (1st July 2016)

3. Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial. (18th May 2022)

5. Association between post-percutaneous coronary intervention bivalirudin infusion and net adverse clinical events: a post hoc analysis of the GLOBAL LEADERS study. Issue 1 (9th December 2019)

6. Chronic total occlusion in an infarct‐related coronary artery and the risk of appropriate ICD therapies. (4th August 2017)

7. Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial. Issue 3 (1st April 2019)

8. Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial. Issue 3 (April 2019)

9. Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial. Issue 10016 (23rd January 2016)

10. Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor. (15th February 2020)